BİLGİÇ, E. Et Al. 2019. Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors. EACR Conference Nanotechnology in Cancer: Engineering for Oncology .

BİLGİÇ, E., BOYACIOĞLU, Ö., VARAN, C., BİLENSOY, E., NEMUTLU, E., KARAOSMANOĞLU, B., ... TAŞKIRAN, Z. E.(2019). Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors . EACR Conference Nanotechnology in Cancer: Engineering for Oncology

BİLGİÇ, ELİF Et Al. "Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors," EACR Conference Nanotechnology in Cancer: Engineering for Oncology, 2019

BİLGİÇ, ELİF Et Al. "Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors." EACR Conference Nanotechnology in Cancer: Engineering for Oncology , 2019

BİLGİÇ, E. Et Al. (2019) . "Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors." EACR Conference Nanotechnology in Cancer: Engineering for Oncology .

@conferencepaper{conferencepaper, author={ELİF KARAKOÇ Et Al. }, title={Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors}, congress name={EACR Conference Nanotechnology in Cancer: Engineering for Oncology}, city={}, country={}, year={2019}}